John Chan, PhD
CEO of the Apelin Project, USA
Dr. John Chan is the CEO of the Apelin Project, which encompasses multiple apelin programs to address critically unmet needs in healthcare. Prior to founding the Apelin Project, Dr. Chan was the founder and CEO of Aspira Scientific, a service provider that commercializes cutting-edge life science and chemistry technologies. Previously, Dr. Chan was the global marketing manager of the chemistry franchise for Sigma-Aldrich and achieved record performance for innovations. With over 15 years of technology and commercial development experience, Dr. Chan has worked on category-defining technologies, including two that are Nobel-winning.
Dr. Chan obtained his PhD in Chemistry from Stanford University and graduated summa cum laude from Duke University with a dual major in Chemistry and Economics. His professional and personal passion is to create a healthier and sustainable future.